The Food and Drug Administration (FDA) yesterday said that there is a temporary supply shortage of Artelac eye drops, as demand for the product increased after another brand withdrew from National Health Insurance (NHI) coverage.
Pharmacist Shen Tsai-ying (沈采穎), a Chinese Nationalist Party legislative-at-large nominee, on Tuesday wrote on her Facebook page: “There is a big shortage of Artelac eye drops. Does everyone know it is caused by the National Health Insurance Administration [NHIA]?”
FDA Deputy Director Cheng Hwei-fang (陳惠芳) yesterday said the NHI-covered Artelac eye drops contain active ingredient hydroxypropyl methylcellulose and are used to temporarily relieve burning, irritation and discomfort caused by dry eyes.
Photo: CNA
The FDA on Jan. 13 last year received a report from the pharmaceutical company saying that due to the shortage of packaging material and ingredients, it would not be able to provide sufficient amounts of the eye drops, Cheng said.
The company imported extra amounts — about seven months’ worth — of eye drops in October last year, but as another brand of eye drops named Tears Naturale with the same active ingredient withdrew from NHI system, there has been a shortage, Cheng said.
FDA Medicinal Products Section senior specialist Yang Bo-wen (楊博文) said before the other brand withdrew from NHI coverage, in one month about 40,000 bottles of Artelac eye drops used to be prescribed under NHI coverage.
Yang said the pharmaceutical company plans to import another batch in April, which should help the supply situation.
In the meantime, while there is a temporary shortage, people who need eye drops are advised to purchase alternative drugs with the same active ingredient and dosage form, but in different sizes, including the NHI-covered Wu-Fu Artificial Tear (五福滴視點眼液), or self-paid Min Young Lubricant Eye Drops (明漾人工淚液點眼液), Chen said.
Separately, the NHIA yesterday said Artelac eye drops are classified as an instruction drug (instructed by physicians, pharmacists or assistant pharmacists) for relieving discomfort caused by dry eyes.
There are 17 types of drugs with the same indications covered by the NHI, including one with the same active ingredient and dosage form, so physicians can instruct people to use the alternative drugs based on their needs, it said.
Regarding Tears Naturale’s withdrawal from the NHI, the NHIA said it has negotiated with the company several times, but the company expressed its wish to withdraw due to a business strategy adjustment.
After two NHI drug coverage and reimbursement criteria meetings, they agreed that it is an instruction drug that is not irreplaceable and should be allowed to return to the self-paid market, the NHIA said, adding that according to the National Health Insurance Act (全民健康保險法), the NHI does not cover the drug anymore.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Taiwan Travelogue (臺灣漫遊錄), which earlier this week became the first Taiwanese novel to win the International Booker Prize, is to be adapted into a television series through a Taiwan-Japan coproduction, producer Chang Chen-yu (張辰漁) said yesterday. Chang, a producer at World Softest Production Film Co, wrote on Facebook that the company had been searching for projects with international appeal that retain a strong Taiwanese identity after colleagues and Japanese partners strongly recommended the novel. After reading the book, Chang said he immediately decided to pursue the screen rights. “A great story has the power to transcend time and borders, and connect countless people,”
RSS